Literature DB >> 19563616

Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.

Barbara Gürtl1, Dagmar Kratky, Christian Guelly, Lefeng Zhang, Gregor Gorkiewicz, Suman Kumar Das, Kuppusamy Palaniappan Tamilarasan, Gerald Hoefler.   

Abstract

In previous experiments, we observed signs of cardiac failure in mice overexpressing lipoprotein lipase (LPL) under the control of a muscle specific promotor and in peroxisome proliferators activated receptor alpha (PPARalpha) knockout mice overexpressing LPL under the control of the same promotor. In our current investigations, we focussed on morphological consequences and changes in mRNA and protein expression in hearts from these animals. mRNA expression was analysed by differential display analysis and Northern blot as well as by cDNA microarray analysis followed by pathway analysis. Protein expression was examined using immunoblot and immunohistochemistry. Fibrosis was determined by chromotrope aniline blue staining for collagen. A distinct increase in the expression of alpha-tubulin mRNA was noted in hearts of all mutant mouse strains compared with the control. This result was paralleled by increased alpha-tubulin protein expression. Using cDNA microarray analysis, we detected an activation of apoptosis, in particular an increase of caspase-3 expression in hearts of mice overexpressing LPL but not in PPARalpha knockout mice overexpressing LPL. This finding was confirmed immunohistochemically. In addition, we identified a distinct interstitial increase in collagen and an increase around blood vessels. In our mouse model, we detect mRNA and protein changes typical for cardiomyopathy even before overt clinical signs of heart failure. In addition, a small but distinct increase in the rate of apoptosis of cardiomyocytes and fibrotic changes contributes to cardiac failure in mice overexpressing LPL, whereas additional deficiency in PPARalpha seems to protect hearts from these effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563616      PMCID: PMC2697556          DOI: 10.1111/j.1365-2613.2009.00647.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  46 in total

1.  Cytoskeletal mechanics in pressure-overload cardiac hypertrophy.

Authors:  H Tagawa; N Wang; T Narishige; D E Ingber; M R Zile; G Cooper
Journal:  Circ Res       Date:  1997-02       Impact factor: 17.367

2.  Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: the significance of type III and VI collagens.

Authors:  M Kitamura; M Shimizu; H Ino; K Okeie; M Yamaguchi; N Funjno; H Mabuchi; I Nakanishi
Journal:  Clin Cardiol       Date:  2001-04       Impact factor: 2.882

3.  Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: II. Cytoskeletal remodeling.

Authors:  X Wang; F Li; S E Campbell; A M Gerdes
Journal:  J Mol Cell Cardiol       Date:  1999-02       Impact factor: 5.000

4.  Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy.

Authors:  M R Zile; G R Green; G T Schuyler; G P Aurigemma; D C Miller; G Cooper
Journal:  J Am Coll Cardiol       Date:  2001-03-15       Impact factor: 24.094

5.  Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose.

Authors:  Michela Zanetti; Alessia Stocca; Barbara Dapas; Rossella Farra; Laura Uxa; Alessandra Bosutti; Rocco Barazzoni; Fleur Bossi; Carlo Giansante; Francesco Tedesco; Luigi Cattin; Gianfranco Guarnieri; Gabriele Grassi
Journal:  J Mol Med (Berl)       Date:  2007-09-18       Impact factor: 4.599

Review 6.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  S Mandard; M Müller; S Kersten
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

7.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

8.  Collagen remodelling in myocardia of patients with diabetes.

Authors:  M Shimizu; K Umeda; N Sugihara; H Yoshio; H Ino; R Takeda; Y Okada; I Nakanishi
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

9.  Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

Authors:  P Tontonoz; E Hu; B M Spiegelman
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

10.  Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy.

Authors:  J Schaper; R Froede; S Hein; A Buck; H Hashizume; B Speiser; A Friedl; N Bleese
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

View more
  18 in total

1.  Transplanted bone marrow mesenchymal stem cells protects myocardium by regulating 14-3-3 protein in a rat model of diabetic cardiomyopathy.

Authors:  Xiaoyan Dong; Fen Zhu; Qun Liu; Yuanheng Zhang; Jun Wu; Wen Jiang; Lei Zhang; Shuguang Dong
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction.

Authors:  Richard W Tsika; Lixin Ma; Izhak Kehat; Christine Schramm; Gretchen Simmer; Brandon Morgan; Deborah M Fine; Laurin M Hanft; Kerry S McDonald; Jeffery D Molkentin; Maike Krenz; Steve Yang; Juan Ji
Journal:  J Biol Chem       Date:  2010-03-01       Impact factor: 5.157

3.  Angiotensin II plays a critical role in alcohol-induced cardiac nitrative damage, cell death, remodeling, and cardiomyopathy in a protein kinase C/nicotinamide adenine dinucleotide phosphate oxidase-dependent manner.

Authors:  Yi Tan; Xiaokun Li; Sumanth D Prabhu; Kenneth R Brittian; Qiang Chen; Xia Yin; Craig J McClain; Zhanxiang Zhou; Lu Cai
Journal:  J Am Coll Cardiol       Date:  2012-04-17       Impact factor: 24.094

4.  The number of cardiac myocytes in the hypertrophic and hypotrophic left ventricle of the obese and calorie-restricted mouse heart.

Authors:  Julia Schipke; Ewgenija Banmann; Sandeep Nikam; Robert Voswinckel; Karin Kohlstedt; Annemarieke E Loot; Ingrid Fleming; Christian Mühlfeld
Journal:  J Anat       Date:  2014-11       Impact factor: 2.610

Review 5.  Mitochondrial network in the heart.

Authors:  Qian Li; Lu-Yu Zhou; Gui-Feng Gao; Jian-Qin Jiao; Pei-Feng Li
Journal:  Protein Cell       Date:  2012-07-01       Impact factor: 14.870

Review 6.  Apoptosis and angiogenesis: an evolving mechanism for fibrosis.

Authors:  Ariel Johnson; Luisa Ann DiPietro
Journal:  FASEB J       Date:  2013-06-19       Impact factor: 5.191

7.  Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis.

Authors:  William R Swindell; Andrew Johnston; Steve Carbajal; Gangwen Han; Christian Wohn; Jun Lu; Xianying Xing; Rajan P Nair; John J Voorhees; James T Elder; Xiao-Jing Wang; Shigetoshi Sano; Errol P Prens; John DiGiovanni; Mark R Pittelkow; Nicole L Ward; Johann E Gudjonsson
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

8.  Role of mitochondrial ATP-sensitive potassium channel-mediated PKC-ε in delayed protection against myocardial ischemia/reperfusion injury in isolated hearts of sevoflurane-preconditioned rats.

Authors:  C Wang; S M Hu; H Xie; S G Qiao; H Liu; C F Liu
Journal:  Braz J Med Biol Res       Date:  2015-03-27       Impact factor: 2.590

9.  Resistance training improves hemodynamic function, collagen deposition and inflammatory profiles: experimental model of heart failure.

Authors:  Jadson P Alves; Ramiro B Nunes; Giuseppe P Stefani; Pedro Dal Lago
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

10.  A novel mechanism by which SDF-1β protects cardiac cells from palmitate-induced endoplasmic reticulum stress and apoptosis via CXCR7 and AMPK/p38 MAPK-mediated interleukin-6 generation.

Authors:  Yuguang Zhao; Yi Tan; Shugang Xi; Yunqian Li; Cai Li; Jiuwei Cui; Xiaoqing Yan; Xiaokun Li; Guanjun Wang; Wei Li; Lu Cai
Journal:  Diabetes       Date:  2013-02-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.